BRAF and pancreatic neoplasm: These findings demonstrate that both siBRAF_Mut1_2′-OMe and siBRAF-Mut2_2′-OMe inhibit the proliferation of a BRAF-mutated pancreatic tumor in the xenograft mouse model.